From: Challenges facing translational research organizations in China: a qualitative multiple case study
TROs | Partners | Research team |
---|---|---|
PUMCH-TMC | Institute of Basic Medical Science of the CAMS, PUMC, and Institute of Pathogen Biology of the Chinese CAMS | Fifty academicians from areas of regenerative therapy using stem cells for central nervous system diseases, the integrated study of the clinical features and molecular mechanisms of pancreatic cancer, HIV/AIDS, chronic metabolic diseases (diabetes, rheumatologic diseases, and the diagnostic and therapeutic use of allergens) |
CTMR of the first affiliated hospital of Zhejiang province | Department of neuropsychological disease, gastrointestinal tumor, cardiovascular disease, reproductive health, kidney disease, visual reconstruction, hemopoietic disease and stem therapy, and laparoscope technology | Twenty-thirty PIs and research groups from the above departments |
TMC of Children’s Hospital of Fudan Univeristy | Children’s Hospital, Biomedicine Research Institute, and the Institute of Developmental Biology and Birth Defects | Ten to 15 research groups with 15–25 principle investigators (PIs), 25–30 research assistants from the areas of pediatrics, developmental biology, and birth defects |
TRCSR | Shanghai Ninth People’s Hospital | Researchers in tissue engineering and stem cell therapy |
TMC of North East of China | Dalian Institute of Chemical Physics, Chinese Academy of Sciences, and Harbin Medical University | Researchers from the Department of Biotechnology of Dalian Institute of Chemical Physics including Drug Separation, Analytical Chemistry, Medicinal Biotechnology, Biomaterials and Biotechnology, Energy, and Environmental Biological Technology |
East TMC of Tongji University | Pudong New District and Technology Committee, Pudong New District Health Bureau, Tongji University, and Shanghai East Hospital | Forty-one staff members, including 36 full-time personnel and 15 PIs in the area of cardiovascular diseases, inflammation and tumors, psychosomatic diseases, and trauma emergency treatment |
TMC of Wuhan Union Hospital | Huazhong University of Science and Technology, Wuhan comprehensive drug research and develop platform, innovative biomedical-clinic research platform, and Wuhan Biolake | Clinical medicine, basic medicine, public health, pharmacy, and bioscience |
TMC of West China Hospital | West China hospital | A total of 1,000 researchers from clinical medicine, pharmacy, biotechnology, chemistry, and materials science |